Inclusion criteria |
---|
patients treated by HD 2 or 3 times a week, for at least 2 months. |
patients able to understand the study procedures. |
patients willing to provide written informed consent. |
Exclusion criteria |
current age < 18 years |
treatment by HDF or high flux HD in the preceding 6 months |
severe incompliance |
life expectancy < 3 months due to non renal disease |
participation to other clinical intervention trials evaluating cardiovascular outcome |